Evidence map›Paper›PMID 26582635›Full record

ReviewChromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology2016

The interplay between centrosomes and the Hippo tumor suppressor pathway.

Amanda F Bolgioni, Neil J Ganem

Abstract readReview
In one paragraph

Review in Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Microbial cell (Graz, Austria) · 2016
    Review
  13. Centrosome amplification, chromosomal instability and cancer: mechanistic, clinical and therapeutic issues.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amanda F BolgioniDepartment of Pharmacology & Experimental Therapeutics, Division of Hematology and Oncology, Boston University School of Medicine, Boston, MA, 02118, USA.
Neil J GanemDepartment of Pharmacology & Experimental Therapeutics, Division of Hematology and Oncology, Boston University School of Medicine, Boston, MA, 02118, USA. nganem@bu.edu.

Funding

TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
Defining novel pathways that arrest genetically unstable tetraploid cellsR00CA154531 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GANEM, NEIL J. · 2013 to 2015
$723k
Defining novel pathways that arrest genetically unstable tetraploid cellsK99CA154531 · NCI · DANA-FARBER CANCER INST · PI GANEM, NEIL J. · 2011 to 2012
$300k
NCI NIH HHS K99 CA154531NCI NIH HHS K99/R00 CA154531-01NCI NIH HHS R00 CA154531NIGMS NIH HHS 5T32GM008541NIGMS NIH HHS T32 GM008541
6 · The paper itself

Abstract

Centrosome amplification is a common feature of both solid and hematological human malignancies. Extra centrosomes are not merely innocent bystanders in cancer cells, but rather promote tumor progression by disrupting normal cellular architecture and generating chromosome instability. Consequently, centrosome amplification correlates with advanced tumor grade and overall poor clinical prognosis. By contrast, extra centrosomes are adversely tolerated in non-transformed cells and hinder cell proliferation. This suggests that in addition to acquiring extra centrosomes, cancer cells must also adapt to overcome the deleterious consequences associated with them. Here, we review evidence that implicates core components of the Hippo tumor suppressor pathway as having key roles in both the direct and indirect regulation of centrosome number. Intriguingly, functional inactivation of the Hippo pathway, which is common across broad spectrum of human cancers, likely represents one key adaptation that enables cancer cells to tolerate extra centrosomes.

Indexed as

Cell ProliferationAnimalsCentrosomeHippo Signaling PathwayHumansNeoplasmsProtein Serine-Threonine KinasesSignal TransductionTumor Suppressor ProteinsProtein Serine-Threonine KinasesTumor Suppressor ProteinsLATSMSTp53TAZTetraploidYAP

Identifiers

PMID26582635
PMCPMC4726471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.